Praga Manuel, Gutiérrez Solís Elena, Morales Enrique
Contrib Nephrol. 2012;176:24-34. doi: 10.1159/000332376. Epub 2012 Jan 30.
Cryoglobulinemic membranoproliferative glomerulonephritis (MPGN) is the more characteristic renal disease associated with hepatitis C virus (HCV) infection. Patients infected with human immunodeficiency virus (HIV) can present, in addition to HIV-associated nephropathy, different types of immune complex glomerulonephritis, including MPGN, IgA nephropathy, non-collapsing focal segmental glomerulosclerosis, membranous nephropathy and lupus-like glomerulonephritis. On the other hand, the incidence of hypertensive nephrosclerosis, diabetic nephropathy and decreased renal function similar to that of elderly patients is increasingly recognized among HIV-infected patients. In spite of the fact that HCV coinfection in HIV patients is a very common problem, affecting approximately 30% of HIV-infected patients, information about the role of HCV in renal diseases of HIV-infected patients is scant. A large proportion of HIV patients with glomerular diseases are coinfected with HCV, and the latter is likely the responsible agent in those cases of cryoglobulinemic MPGN reported in HIV-infected patients. Participation of HCV in other types of HIV-related glomerular diseases is uncertain. Patient and renal survival in glomerular diseases of patients coinfected with HIV and HCV is very poor, but some studies suggest that antiretroviral therapy might change this dismal prognosis. Information about the effect of specific anti-VHC therapy or immunosuppressive agents in these patients is very limited.
冷球蛋白血症性膜增生性肾小球肾炎(MPGN)是与丙型肝炎病毒(HCV)感染相关的更具特征性的肾脏疾病。感染人类免疫缺陷病毒(HIV)的患者,除了会出现与HIV相关的肾病外,还可能出现不同类型的免疫复合物性肾小球肾炎,包括MPGN、IgA肾病、非塌陷型局灶节段性肾小球硬化、膜性肾病和狼疮样肾小球肾炎。另一方面,在HIV感染患者中,高血压性肾硬化、糖尿病肾病以及与老年患者相似的肾功能下降的发生率越来越高。尽管HIV患者合并HCV感染是一个非常常见的问题,约30%的HIV感染患者受其影响,但关于HCV在HIV感染患者肾脏疾病中的作用的信息却很少。很大一部分患有肾小球疾病的HIV患者合并HCV感染,在HIV感染患者中报告的那些冷球蛋白血症性MPGN病例中,后者可能是致病因素。HCV在其他类型的HIV相关肾小球疾病中的作用尚不确定。HIV和HCV合并感染患者的肾小球疾病患者的肾脏存活率和总体生存率都非常低,但一些研究表明抗逆转录病毒疗法可能会改变这种糟糕的预后。关于特定抗HCV疗法或免疫抑制剂对这些患者的影响的信息非常有限。